Healthcare -
Biotechnology - NASDAQ - US
$ 39.9894
6.12 %
$ 6.35 B
Market Cap
157.2
P/E
TGTX - ACCOUNTS PAYABLE
Accounts Payable TGTX - TG Therapeutics, Inc.
58.3 M
LAST VALUE
17.79%
2 YEAR CAGR
14.18%
5 YEAR CAGR
30.75%
10 YEAR CAGR